These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 18328218

  • 21. Localized nephrogenic fibrosing dermopathy: Aberrant dermal repairing?
    Deng AC, Bilu Martin D, Sina B, Gaspari A.
    J Am Acad Dermatol; 2008 Feb; 58(2):336-9. PubMed ID: 18222333
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.
    Daram SR, Cortese CM, Bastani B.
    Am J Kidney Dis; 2005 Oct; 46(4):754-9. PubMed ID: 16183432
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema.
    Kucher C, Xu X, Pasha T, Elenitsas R.
    J Cutan Pathol; 2005 Aug; 32(7):484-90. PubMed ID: 16008692
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Nephrogenic systemic fibrosis following hair-dye ingestion induced acute renal failure.
    Reddy IS, Somani VK, Swarnalata G, Maitra S.
    Indian J Dermatol Venereol Leprol; 2010 Aug; 76(4):400-3. PubMed ID: 20657123
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Case 35-2004: nephrogenic fibrosing dermopathy.
    Cowper SE, Bucala R, LeBoit PE.
    N Engl J Med; 2005 Apr 21; 352(16):1723-4; author reply 1723-4. PubMed ID: 15846862
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure.
    Swartz RD, Crofford LJ, Phan SH, Ike RW, Su LD.
    Am J Med; 2003 May 21; 114(7):563-72. PubMed ID: 12753880
    [Abstract] [Full Text] [Related]

  • 36. Nephrogenic fibrosing dermopathy in a patient with systemic lupus erythematosus and acute lupus nephritis.
    Sanchez-Ross M, Snyder R, Colome-Grimmer MI, Blumberg M, Huttenbach Y, Raimer S.
    Pediatr Dermatol; 2007 May 21; 24(5):E36-9. PubMed ID: 17958777
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cutaneous Rosai-Dorfman disease.
    Merola JF, Pulitzer M, Rosenman K, Brownell I.
    Dermatol Online J; 2008 May 15; 14(5):8. PubMed ID: 18627744
    [Abstract] [Full Text] [Related]

  • 39. Case 35-2004: nephrogenic fibrosing dermopathy.
    Taylor RA, Levine JM, Jimenez SA.
    N Engl J Med; 2005 Apr 21; 352(16):1723-4; author reply 1723-4. PubMed ID: 15843679
    [No Abstract] [Full Text] [Related]

  • 40. Scleromyxedema-like lesions of patients in renal failure contain hyaluronan: a possible pathophysiological mechanism.
    Neudecker BA, Stern R, Mark LA, Steinberg S.
    J Cutan Pathol; 2005 Oct 21; 32(9):612-5. PubMed ID: 16176298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.